R Squared’s Boston Scientific BSX Stock Holding History

R Squared’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9,963	Closed	-$625K	–	547
2026 Q1	$625K	Sell	9,963 -20,754	-68%	-$1.66M	0.34%	70
2025 Q4	$2.93M	Sell	30,717 -316	-1%	-$31K	1.37%	7
2025 Q3	$3.03M	Buy	31,033 +15,677	+102%	+$1.62M	1.3%	2
2025 Q2	$1.65M	Buy	15,356 +7,826	+104%	+$792K	0.91%	13
2025 Q1	$760K	Buy	7,530 +7,440	+8,267%	+$749K	0.81%	17
2024 Q4	$8.04K	Buy	+90	New	+$7.92K	0.01%	1204

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

R Squared's BSX Position: Q2 2026 in Review

R Squared sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 9,963 shares — an estimated $625K sold.

R Squared first reported a position in BSX in Q4 2024 and held it in 6 quarters. The position peaked at $3.03M in Q3 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

R Squared reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
R Squared sold 9,963 Boston Scientific shares in Q2 2026, an estimated $625K.
R Squared first reported a position in Boston Scientific in Q4 2024 and held it in 6 quarters.
R Squared's Boston Scientific position peaked at $3.03M in Q3 2025.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.